Impact of tumor hypoxia and anemia on radiation... (2002 study) Skip to main content
Review The oncologist 2002

Impact of tumor hypoxia and anemia on radiation therapy outcomes.

Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D, The oncologist, 2002

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors reviewed the medical literature on how low oxygen levels in tumors and low hemoglobin (anemia) affect the results of radiation therapy for cancer.

What They Found

This review found that low oxygen in solid tumors is linked to weaker response to radiation, and that low hemoglobin before or during radiation is a risk factor for poor local disease control and survival. In head and neck or cervical cancer, tumor oxygen levels below 2.5-10 mm Hg were associated with less local tumor control and lower disease-free and overall survival. The abstract lists hyperbaric oxygen among several hypoxia-directed treatments, along with fluosol infusion, carbogen breathing, and sensitizers. It says these treatments showed the potential to increase the effectiveness of curative-intent radiation. Studies used different cutoffs for low hemoglobin, from 9 to 14.5 g/dl, and the best cutoff is unclear.

What This Means for Canadian Patients

For people having radiation for a solid tumor, this review suggests that tumor oxygen and hemoglobin levels may matter for how well treatment works. The abstract names hyperbaric oxygen only as one of several approaches aimed at low tumor oxygen. It gives no HBOT protocol, such as pressure or number of sessions, and does not report results for HBOT on its own. Patients can ask their radiation oncology team about their own hemoglobin levels.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a narrative review, not a new trial, and it reports no pooled numbers. The abstract says the best hemoglobin and oxygen thresholds are unclear, may differ by tumor type, and need more evaluation.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Radiation Injury
Source Pubmed
PubMed ID 12490737
Year Published 2002
Journal The oncologist
MeSH Terms Anemia; Dose-Response Relationship, Radiation; Head and Neck Neoplasms; Humans; Hypoxia; Neoplasm Recurrence, Local; Oxygen; Prognosis; Radiation-Sensitizing Agents; Survival Analysis; Treatment Outcome

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology